PTPN11 and chronic myelogenous leukemia, BCR-ABL1 positive: We found significantly less Icsbp expression in CD34+ CML cells versus control (p<0.0001, n=3), but Icsbp expression was significantly increased in these cells by DN-Shp2 or DN-Gas2 (p<0.001, n=3).